SMS Pharmaceuticals Q3 Results
- BSE: 532815
- NSE: SMSPHARMA
- ISIN: INE812G01025
- Sector: Biotechnology & Drugs
BSE
397
-2.65 (-0.66%)
-2.65 (-0.66%)Volume8.56 K
Updated: Tue 14 Jul, 2026 | 15:01:29
NSE
398.90-0.90 (-0.23%)
-0.90 (-0.23%)Volume3.64 L
Updated: Tue 14 Jul, 2026 | 14:46:38
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - SMS Pharmaceuticals Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 176.82 | 173.90 | -13.36% | 140.49 | 18.80% |
| Depreciation/ Amortization | 10.02 | 8.62 | -0.05% | 8.01 | 15.18% |
| Operating Income | 33.63 | 22.84 | -12.29% | 20.99 | 37.19% |
| Net Income | 23.47 | 14.10 | -7.27% | 11.48 | 28.67% |
| Other Operating Expenses Total | 10.19 | 9.67 | 10.17% | 7.69 | -33.20% |
| Net Income Before Taxes | 31.16 | 19.54 | -8.47% | 16.53 | 38.87% |
| Total Revenue | 210.45 | 196.75 | -13.19% | 161.48 | 21.40% |
| Selling/ General/ Admin Expenses Total | 21.05 | 17.93 | 9.35% | 14.02 | 12.91% |
| Diluted Normalized EPS | 2.59 | 1.67 | -8.80% | 1.36 | 20.47% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.